1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow HSCT: new trials by email Literature Review of HSCT trials Research Report on HSCT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reduced Post-transplant Cyclophosphamide Dose in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies Cyclophosphamide 35mg/kg/day, Cyclophosphamide 50mg/kg/day - GVHD - Graft-Versus-Host Disease, HSCT | Phase 3 | Recruiting | Assistance Publique - Hôpitaux de Paris | 180 | 2026-09-29 | 2026-11-10 |
Cyclophosphamide (1)
Assistance Publique - Hôpitaux de Paris (1)
France (1)